Spravato is an esketamine therapy that works quickly and has lasting efficacy, but it requires administration under supervision of a healthcare provider, and can lead to adverse events such as ...

Prior ketamine or esketamine users were excluded. Other exclusion criteria included non-responsiveness to electroconvulsive ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Prior ketamine or esketamine users were excluded. Other exclusion criteria included non-responsiveness to electroconvulsive therapy for the current episode, vagal nerve or deep brain stimulation ...

Manufacturer Janssen says Esketamine can lift a patient's mood ... In a statement, Janssen said it offers "a potential therapy for adults living with treatment-resistant depression," including ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

An estimated one-third of patients with major depressive disorder have treatment-resistant depression (TRD), characterized by ...

Esketamine is currently FDA-indicated as an adjunctive treatment after two failed ... we believe that it is most appropriate to compare ketamine to other commonly utilised augmentation strategies for ...

Our Core Self approach is a comprehensive, integrative treatment that combines medication management, Spravato (esketamine) therapy, and psychotherapy to create a personalized path to healing.

I provide medication management and Spravato (esketamine) therapy, an innovative treatment for adults with treatment-resistant depression. My ideal patient seeks compassionate care for ADHD ...

The study found those using esketamine had a much greater improvement ... and could be used for people instead of electroconvulsive therapy. Prof Mitul Mehta from King's College told the BBC ...